Pathways to gene identification in rheumatoid arthritis: PTPN22 and beyond

Immunological Reviews

Volumn 204, Issue , 2005, Pages 74-86

  Gregersen, Peter K ^a  

^a Institute for Medical Research at North Shore LIJ   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE N22; T LYMPHOCYTE RECEPTOR; TRYPTOPHAN; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; DISEASE PREDISPOSITION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HUMAN; LINKAGE ANALYSIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; CHROMOSOMES, HUMAN, PAIR 18; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 16244411098     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2005.00243.x     Document Type: Review

References (53)

1. Gregersen PK. Genetics of rheumatoid arthritis: confronting complexity. Arthritis Res 1999;1:37-44.
2. Gabriel S. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001;27:269-281.
3. Ward RH, Hasstedt SJ, Clegg DO. Population prevalence of rheumatoid arthritis is lower than forwerly supposed. Arthritis Rheum 1992;5:S129.
4. Seldin M, Amos C, Ward R, Gregersen PK. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999;42:1071-1079.
5. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996;85:311-318.
6. Silman AJ, et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993;32:903-907.
7. MacGregor AJ, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000;43:30-37.
8. Wolfe F. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. J Rheumatol 2000;27:630-637.
9. Mattey DL, et al. Smoking and disease severity in rheumatoid arthritis: association with polymorphism at the glutathione S-transferase M1 locus. Arthritis Rheum 2002;46:640-646.
10. Segal S, Hill AV. Genetic susceptibility to infectious disease. Trends Microbiol 2003;11:445-448.
11. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995;11:241-247.
12. Cornelis F, et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 1998;95:10746-10750.
13. Jawaheer D, et al. A genome-wide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Human Genet 2001;68:927-936.
14. Jawaheer D, et al. Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum 2003;48:906-916.
15. MacKay K, et al. Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum 2002;46:632-639.
16. Shiozawa S, et al. Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol 1998;10:1891-1895.
17. Jawaheer D, Gregersen PK. The search for rheumatoid arthritis susceptibility genes: a call for global collaboration. Arthritis Rheum 2002;46:582-584.
18. John S, et al. Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites. Am J Hum Genet 2004;75:54-64.
19. Hall FC, et al. Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis. Q J Med 1996;89:821-829.
20. Ueda H, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003;423:506-511.
21. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome. Nat Genet 2001;29:229-232.
22. Rioux JD, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001;29:223-228.
23. Jeffreys AJ, Kauppi L, Neumann R. Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex. Nat Genet 2001;29:217-222.
24. Lubberts E, et al. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis. Arthritis Rheum 2002;46:3055-3064.
25. Begovich AB, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004;75:330-337.
26. Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies. Nature 2004;429:446-452.
27. Cloutier JF, Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 1999;189:111-121.
28. Gregorieff A, Cloutier JF, Veillette A. Sequence requirements for association of protein-tyrosine phosphatase PEP with the Src homology 3 domain of inhibitory tyrosine protein kinase p50(csk). J Biol Chem 1998;273:13217- 13222.
29. Hasegawa K, Martin F, Huang G, Tumas D, Dieche L, Chan AC. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 2004;303:685-689.
30. Weyand CM, Kurtin PJ, Goronzy JJ. Ectopic lymphoid organogenesis: a fast track for autoimmunity. Am J Pathol 2001;159:787-793.
31. Dorner T, Egerer K, Feist E, Burmester GR. Rheumatoid factor revisited. Curr Opin Rheumatol 2004;16:246-253.
32. Williams DG, Moyes SP, Mageed RA. Rheumatoid factor isotype switch and somatic mutation variants within rheumatoid arthritis synovium. Immunology 1999;98:123-136.
33. Davidson A, Bridges SL Jr. Autoimmunity. In: St Clair EW, Pisetsky DS, Haynes BF, eds. Rheumatoid Arthritis. Philadelphia: Lippincott Williams and Williams, 2004.
34. Halldorsdottir HD, Jonsson T, Thorsteinsson J, Valdimarsson H. A prospective study on the incidence of rheumatoid arthritis among people with persistent increase of rheumatoid factor. Ann Rheum Dis 2000;59:149-151.
35. Wang H, Schlomchik MJ. Regulation of autoreactive anti-IgG (rheumatoid factor) B cells in normal and autoimmune mice. Immunol Res 1999;19:259-270.
36. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002;416:603-607.
37. Bennett SR, Falta MT, Bill J, Kotzin BL. Antigen-specific T cells in rheumatoid arthritis. Curr Rheumatol Rep 2003;5:255-263.
38. Goronzy JJ, Zettl A, Weyand CM. T cell receptor repertoire in rheumatoid arthritis. Int Rev Immunol 1998;17:339-363.
39. + T cell population of rheumatoid arthritis patients. J Immunol 1996;156:852-858.
40. + T cell expansions in the peripheral blood of rheumatoid arthritis patients. J Exp Med 1993;177:1623-1631.
41. + T cells in health and disease: aging, infection, or immune regulation? Hum Immunol 1996;48:68-76.
42. Bottini N, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004;36:337-338.
43. Kyogoku C, et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004;75:504-507.
44. Arbuckle MR, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-1533.
45. Hoppu S, Ronkainen MS, Kulmala P, Akerblom HK, Knip M. Childhood Diabetes in Finland Study Group. GAD65 antibody isotypes and epitope recognition during the prediabetic process in siblings of children with type I diabetes. Clin Exp Immunol 2004;136:120-128.
46. Strieder TG, Prummel MF, Tijssen JG, Endert E, Wiersinga WM. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol (Oxf) 2003;59:396-401.
47. Suzuki A, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003;34:395-340.
48. Tokuhiro S, et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 2003;35:341-348.
49. van Venrooij WJ, Pruijn GJ. Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res 2000;2:249-251.
50. Barton A, et al. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum 2004;50:1117-1121.
51. Smyth D, et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes. 2004; 53:3020-3023.
52. Lee AT, et al. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a does32 dependent manner but not with HLA shared epitope status. Genes and Immunity (in press).
53. Begovich AB, et al. The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. Am J Hum Genet 2005; 76: 184-187.